From Simple Questions to Scalable Solutions: Inside GW’s Next Healthcare Innovator

If you want to find Aditya Loganathan refining an idea, you won’t find him behind a desk. You’ll find him in a hospital cafeteria.

Between shift breaks and coffee refills, he approaches nurses, physicians, and hospital staff with what he jokes are “annoying questions.” He might stop a nurse in the hallway to ask about the small frustrations that arise during a shift, or catch a physician to ask for feedback on an idea he’s been developing.

These quick exchanges are not random. For Loganathan, they are how he tests his ideas in their earliest stages.

Loganathan, an MBA student at the George Washington University, is an emerging entrepreneur and aspiring physician. After graduating with his bachelor’s degree in biology in 2023, he began working in clinical research while preparing to apply to medical school. There, a few key mentors with active roles in business and entrepreneurship encouraged him to explore the possibilities of healthcare innovation. Inspired by their work, Loganathan decided to pursue his MBA and begin developing ventures of his own.

Aditya Loganathan, an MBA student at the George Washington University, focuses on building healthcare ventures grounded in everyday clinical challenges.

Loganathan is no stranger to testing his ideas publicly. He is currently a semifinalist in GW’s 2026 New Venture Competition, an annual startup competition where students, faculty, and alumni teams develop and pitch prospective ventures for mentorship and funding. He returns to the competition following a first-place finish in 2025.

GuideGuard: Winning Idea for 2025 New Venture Competition

His winning project that year, GuideGuard, redesigned the traditional guidewire used during catheterization procedures. The device was developed to reduce the risk of guidewire retention, which occurs when the thin wire used to guide the catheter becomes lost inside the patient during the procedure. While uncommon, this error can lead to serious complications if it remains undetected.

Aditya Loganathan (left) and his team celebrate their first-place finish at the 2025 New Venture Competition for GuideGuard, a device designed to reduce guidewire retention during catheterization procedures.

GuideGuard’s success marked Loganathan’s first major venture. The project required him to learn everything from prototyping and computer-aided design to patents and licensing. More importantly, it taught him that forming an idea is only half of the work. Understanding the problem is what truly makes it impactful.

Early on in his entrepreneurial journey, Loganathan pitched ideas for nearly anything that struck him as inefficient, from a new toothbrush design to a horse transportation system. Creativity was never an issue. Instead, what he lacked was the discernment to know which ideas were worth pursuing.

Through his work in research within GW’s emergency department, and under the guidance of mentors who pushed him to think critically, Loganathan became more deliberate in how he approached new ideas. Rather than jumping straight to solutions, he began asking a different set of questions:

Where is the failure point?

Who does this problem affect?

Is it frequent enough to matter?

What prevents it from being solved?

“Everybody’s got a cool solution,” he remarked. “But who’s actually going to use it?”

With that lesson in mind, Loganathan returned to the NVC in 2026 with four new ventures in the running, each rooted in problems he encounters daily in his work in the emergency department.

One of these is Policare.

Policare emerged from the growing reliance on travel nurses and temporary physicians in the hospital setting. Although these providers are clinically proficient, they are often onboarded in just a matter of days, then expected to navigate dense policy manuals and complicated documentation systems. 

In practice, this might require a provider to step away from a patient just to confirm how a procedure should be documented or which protocol applies. Confusion, inefficiency, and even mistakes are common, costing providers valuable time and distracting from patient care.

Policare addresses this problem through an AI-driven chatbot trained specifically on a hospital’s internal policies and procedures. Instead of digging through physical manuals and documents, providers can chat with the system in real time and receive guidance based on the established policies, resulting in decreased liability, improved confidence, and better outcomes. The idea gained momentum early and fast, and Loganathan’s team prepared for a pilot launch. 

As Policare developed, however, Loganathan confronted an important realization: in today’s technological landscape, building this kind of software is no longer much of a challenge. This replicability became a crucial factor when considering potential competitors.

“In today’s world, anyone can build an AI chatbot in a couple of hours,” he said. “That’s not the moat.”

If technology for something like Policare could be replicated overnight, then Loganathan and his team needed something more defensible — something with a lasting competitive advantage. For Policare, they realized that meant gaining credibility and institutional trust. Rather than relying on the software itself, they began focusing on integration. This meant working directly with hospital quality officers, aligning themselves with policy systems, and embedding the platform in existing structures. Although the chatbot itself could be rebuilt, the relationships and brand behind it could not.

The same mindset shaped another of his 2026 ventures: High Enroller.

The idea behind High Enroller stemmed from Loganathan’s daily work enrolling patients in emergency department clinical trials. Oftentimes, the volume of research requiring clinical trial participants fluctuates wildly. Some months might have multiple studies being run at once, while others may have none. Maintaining a full research staff year-round is inefficient, yet reducing staffing during slower periods results in departments being unprepared when activity increases once again.

“Sometimes we have five studies going on and sometimes we have zero,” he explained. “We can’t afford to keep staffing that high year-round, but we also don’t want to let everyone go.”

High Enroller offers a solution to this by providing on-demand research assistant staffing for clinical trial sites. Instead of maintaining a full research staff year-round, these hospitals can bring in trained assistants during periods when studies are actively enrolling patients. When enrollment slows or trials end, those staffing costs disappear, allowing departments to adjust their staffing based on study volume. 

In many ways, High Enroller reflects Loganathan’s broader approach to innovation.

“If you see the [ventures] that do well,” Loganathan remarked, “they’re often the ones that we actually live every day.” 

Addressing these everyday problems requires persistence. For Loganathan, that means showing up. It means asking the “annoying” questions. It means striking up conversations in cafeterias and stairwells, sending messages that might not get a reply, and being willing to hear complicated feedback.

“If you don’t fight for it, no one’s going to care,” Loganathan said. “Just don’t quit.”

As he prepares for medical school, his understanding of impact has expanded. What began as a desire to improve individual patient encounters has evolved into something broader: a commitment to improving the systems that shape those encounters in the first place.

“Innovation transcends any single patient encounter,” he said. “If you can improve a process, it lives beyond you.”